Athenex Announces $50 Million Revenue Interest Financing with Sagard Healthcare Royalty Partners

NEXT STORY
Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates
PREV STORY
Madrigal Pharmaceuticals Reports 2020 Second Quarter Financial Results and Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Wegovy™ demonstrated significant and sustained weight loss in two-year study in adults with obesity

author_avatar
NASDAQ Market News

Crown Bioscience Announces Second Quarter Results, Appoints Dr. Yangzhou Wang as Sr. VP of Global Operations

SANTA CLARA, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary ...

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering

TEL-AVIV, Israel and RALEIGH, N.C., Dec. 06, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...

author_avatar
NASDAQ Market News